SCHEMBL2401451

SCHEMBL2401451

Cc1c(Nc2ccc(S(C)(=O)=O)cc2F)ncnc1OC1CCN(CCCC=O)CC1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.65
CYP2C9 P11712 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2405518 0.98 GPR119 (0.65) GPR119CYP2C9
SCHEMBL6368465 0.94 GPR119 (0.67) GPR119CYP2C9
SCHEMBL5189166 0.89 GPR119 (0.68) GPR119CYP2C9
SCHEMBL5187894 0.87 GPR119 (0.70) GPR119CYP2C9
SCHEMBL6364037 0.85 GPR119 (0.63) GPR119CYP2C9
SCHEMBL2406808 0.83 GPR119 (0.62) GPR119CYP2C9
SCHEMBL5189027 0.83 GPR119 (0.73) GPR119CYP2C9
SCHEMBL5048678 0.82 GPR119 (0.62) GPR119CYP2C9
SCHEMBL1890870 0.81 GPR119 (0.69) GPR119
SCHEMBL389611 0.81 GPR119 (0.73) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4777244-B2 2011-09-21 JP claimed
JP-2007528856-A 2007-10-18 JP claimed
EP-1644357-A1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2006-04-12 EP claimed
WO-2005007647-A1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2005-01-27 WO claimed